
Secretary Of HHS Kennedy Fires Entire CDC's Vaccine Advisory Committee
Secretary of Health and Human Services, Robert F. Kennedy Jr., is making good on his promise to radically reshape the vaccine policy landscape as he ousts the entire Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. In a press release issued by the Department of HHS on June 9th, Kennedy says he's doing this in order to restore the public's trust in vaccine science in America. It's unknown who Kennedy will hire to replace committee members, but it's possible they may share his skeptical views of vaccines. In turn, this could have the effect of increasing the public's vaccine hesitancy.
ACIP advises the director of the CDC on which vaccines approved by the Food and Drug Administration should be used; for example, recommending which groups of people ought to be vaccinated, at what doses and when. ACIP's guidance is not binding, though CDC almost always follows it and provides recommendations to the public on what is to be included in the United States adult and childhood immunization schedules.
Neither the Secretary of HHS nor the CDC director can unilaterally ban vaccines. But they can alter the CDC's messaging, fire and hire ACIP committee members and revise vaccination scheduling.
Moreover, the Secretary of HHS together with heads of agencies under his oversight can pursue changes in guidance that restructure regulatory pathways for vaccine development and revise recommendations to the public on who should get vaccinated.
In a major policy shift last month, Food and Drug Administration officials proposed requiring new clinical trial research with respect to the effectiveness of COVID-19 vaccines in healthy people under 65, including pregnant women, before issuing an updated approval for a broader population.
And we observed a preview of the new FDA approach when the agency made an unusual decision in May to limit the approval of the nation's only non-mRNA coronavirus vaccine, Novavax's nuvaxovid, for use only in adults 65 and older or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19. And on May 31st, Moderna won approval for its latest COVID-19 vaccine with a similar set of limits.
To be indicated for a broader population, the FDA plans to require that vaccine makers conduct booster trials to demonstrate effectiveness in people under 65 or without certain risks. These trials could take a year to complete, according to a STAT report. As such, it's not something that can be accomplished prior to the autumn, even if Novavax, Pfizer, or Moderna, wished to pursue this pathway.
Changes are also occurring at CDC in terms of its messaging on vaccines. While all the standard childhood and adult vaccines are still on the website, the messaging in some instances incorporates more of an 'informed consent' approach than a recommendation. Informed consent is the principle that people should be notified of all the risks, as well as benefits, of any medical intervention they receive or any therapeutic they are prescribed.
All of the changes we're seeing shouldn't come as a surprise. Kennedy's vaccine-skeptic views are well-known. And while he told the podcaster Lex Fridman in 2023 that some vaccines 'are probably averting more problems than they're causing,' he also maintained that 'there's no vaccine that is, you know, safe and effective.' In March, he commissioned a large-scale study to investigate debunked theories that link autism to the measles, mumps and rubella vaccine. And, amid an outbreak of measles this year that started in Texas and spread to surrounding states and cost the lives of three people, Kennedy appeared at times to downplay its severity.
Kennedy has also been outspoken about the existing organizational framework within his department, in which he says that with respect to vaccines there are conflicts of interest. In announcing today's purge of the entire ACIP committee, Kennedy cited the pharmaceutical industry's close relationship with government agencies and ACIP that advises them. But it's unclear what Kennedy means when current ACIP members include academics, a chief medical officer of a community health center, a state public health higher-up and the owner of a family medicine practice.
Kennedy defends himself as merely wanting placebo-controlled trials prior to licensure and no more strict vaccine mandates. However, the vaccines he criticizes are typically subject to such clinical trials. Furthermore, arguably the mandates Kennedy opposes, which have been in place since the 1960s, have helped to contribute to a dramatic decline in childhood infectious diseases.
From smallpox inoculations—which began in the late 18th century and ended when the disease was eradicated in the 1970s—to mumps, rubella, tetanus, diphtheria, polio and measles immunizations, vaccinations have saved millions of lives and prevented crippling and life-threatening illnesses from occurring. To illustrate, mass vaccination programs with single or combination—measles, mumps and rubella—shots began in the 1960s and quickly suppressed the spread of measles in most developed countries. The measles vaccine is 'sterilizing,' which means it not only prevents illness, but also transmission.
The American public is already increasingly vaccine-hesitant around standard childhood immunizations. This is likely to lead to more outbreaks and preventable severe illness and death. Should Kennedy appoint like-minded vaccine skeptics to the ACIP committee, that could undermine the public's trust in vaccines even further.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
32 minutes ago
- Wall Street Journal
RFK Jr. Conducts His Vaccine Purge
We'd like to conclude we were wrong to oppose Robert F. Kennedy Jr. to run the Health and Human Services Department, but alas, no. The latest evidence is his purge of a vaccine advisory panel. Mr. Kennedy announced his not-so-clean sweep of the Advisory Committee on Immunization Practices (ACIP) in these pages on Tuesday. The panel of outside experts advises the Centers for Disease Control and Prevention on vaccine schedules. Its recommendations determine which vaccines insurers must cover without patient cost-sharing.


CBS News
35 minutes ago
- CBS News
MACV's Summer Salute connects veterans with lifesaving resources, with help from WCCO viewers
In Minnesota's latest budget agreement, the state's veterans got a little over $1 million in funding. On Tuesday, Hundreds of veterans were connected to lifesaving resources at the third annual Minnesota Assistance Council for Veterans' Summer Salute at CHS Field. The largest of its kind, high-impact outreach features 77 service providers to deliver critical same-day support to homeless and at-risk veterans. "Every two years the state does a new budget, and this year was tight for a lot of programs," said Brian Peterson. MACV was one of those organizations concerned because its funding was on the chopping block, meaning many veterans would be at risk of losing their housing, among other things. "We had to make the case for why this money matters, how it makes a difference in our homelessness response system," Peterson said. "We got the tools in place that if they are homeless are a risk of losing their housing, we can help them on a pathway to housing stability." Phone calls and emails from WCCO's viewers made the difference. "We are fully restored on funding from the state and the system is strong and we really believe that we continue to build on it, " Peterson said. It's a win for all veterans, including Dy'wane Bailey. "I had brain surgery, bro, scar right there, you see it, go right here, " said Bailey. Recently retired, he fell on hard times after a health scare. "Aneurysm, stroke and a seizure, "Bailey said. "I didn't have to worry about losing my voucher, I didn't have to worry about it, their main concern was me getting healthy again, " Bailey said. He and others are thankful for community support that led to events like these that connect veterans with much-needed resources to avoid them being homeless. "They are talking about cutting funding from the VA, firing people and stuff, so when you have other entities to step up that makes a difference, " Bailey said. The Legislature passed the veteran resources bill at the end of May. MACV thanks WCCO viewers for helping lawmakers understand the importance of supporting veterans.
Yahoo
38 minutes ago
- Yahoo
PA bills will expand access to opioid overdose reversal agents
PENNSYLVANIA (WTAJ) — Two bills will soon be introduced to help provide more resources to first responders and law enforcement to fight opioid overdoses. Representatives Chris Pielli and Brian Munroe, in a memo to lawmakers, wrote that the current practice in Pennsylvania is 'outdated.' Noting that the Department of Health only allows the use of naloxone despite other options being available. The CDC reported that deaths involving opioids were estimated to be over 54,000. However, from December 2023 to December 2024, drug overdose deaths in Pennsylvania dropped by 29.94%. Two states, Nevada and South Dakota, were the only ones with increases. Both saw increases of over 4%. Pennsylvania lawmakers advance bill expanding no-cost breast cancer diagnostics Naloxone is used by law enforcement and other first responders to reverse the effects of an opioid overdose. Naloxone works by attaching itself to opioid receptors and then reversing and blocking the effects of opioids. In the CDC's most recent report, they also listed synthetic opioids, like fentanyl, as being the cause of the largest number of overdose deaths. Fentanyl is 50 times stronger than heroin and 100 times stronger than morphine, according to the representatives. They argue that fentanyl is so strong that it can outlast the effects of naloxone and cause people to 're-overdose.' That's why they feel that first responders should have access to things like nalmefene, which is a longer-lasting opioid antagonist. Currently, nalmefene is only available by prescription. 'While naloxone is a crucial tool for first responders and law enforcement, it cannot be our only option,' The representatives said. The two bills that they will be introducing would do the following: Amend the Controlled Substance Drug, Device, and Cosmetic Act to allow nalmefene as an approved opioid antagonist for use over the counter. Direct the Pennsylvania Department of Health to change their current standing order to include nalmefene as an approved opioid reversal agent for over the counter use. 'We cannot continue to discount the ability of other opioid antagonists to save lives. While our policy continues to stagnate, the illicit drug market evolves, adapts, and finds new ways to draw Pennsylvanians into the throes of addiction or, in an unfortunate number of cases, death,' the representatives added. If you or someone you know is struggling with substance abuse, you can contact the Substance Abuse and Mental Health Services Administration's free, confidential, 24/7, 365-day-a-year treatment referral and information service at 1-800-662-HELP (4357). Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.